INOVIO PHARMACEUTICALS INC (INO:NASDAQ)
$1.06 0.01 (0.9524%)
Analysed INOVIO PHARMACEUTICALS INC (INO:NASDAQ) News Sources
Inovio (INO) Loses 32.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
03-04-2026
yahoo.com
INOVIO Announces Pricing of $17.5 Million Public Offering
02-04-2026
yahoo.com
INOVIO Announces Proposed Public Offering
02-04-2026
yahoo.com
INOVIO to Participate in Upcoming Scientific Conference
01-04-2026
yahoo.com
Novo Nordisk's Awiqli Gets FDA Approval for Type II Diabetes
27-03-2026
yahoo.com
KOD Stock Soars on Promising Phase III Data for Eye Disease Candidate
27-03-2026
yahoo.com
SRPT Stock Surges on Promising Early Results From siRNA Programs
26-03-2026
yahoo.com
BEAM Eyes Global Expansion of AATD Study After Strong Early Data
26-03-2026
yahoo.com
NVO Eyes Global Expansion of Diabetes Drug After Strong Phase II Data
25-03-2026
yahoo.com
Rezolute Stock Gains After FDA Meeting on Ersodetug Program Update
25-03-2026
yahoo.com
What is the current price of INOVIO PHARMACEUTICALS INC (INO:NASDAQ)?
The current price of INOVIO PHARMACEUTICALS INC (INO:NASDAQ) is $1.06.
INOVIO PHARMACEUTICALS INC (INO:NASDAQ) absolute price change since previous trading day?
The absolute price change of INOVIO PHARMACEUTICALS INC (INO:NASDAQ) since the previous trading day is $0.01.
INOVIO PHARMACEUTICALS INC (INO:NASDAQ) percentage price change since previous trading day?
The percentage price change of INOVIO PHARMACEUTICALS INC (INO:NASDAQ) since the previous trading day is 0.9524%.
What is the most recent average sentiment score for INOVIO PHARMACEUTICALS INC (INO:NASDAQ)?
The most recent average sentiment score for INOVIO PHARMACEUTICALS INC (INO:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for INOVIO PHARMACEUTICALS INC (INO:NASDAQ)?
The most recent sentiment for INOVIO PHARMACEUTICALS INC (INO:NASDAQ) is .
SEC-8K** Filing Available For INOVIO PHARMACEUTICALS INC (INO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.